OverviewSuggest Edit
LivaNova is a global medical technology company. The Company provides cardiac surgery, neuromodulation and cardiac rhythm management solutions.
| Type | Public | |
| Founded | 2015 | |
| HQ | London, GB | Map |
| Website | livanova.com | |
| Employee Ratings | More |
Recent NewsAll News
- Global Heart Valve Repair and Replacement Devices Market to 2023 - Key Vendors are Abbott, Boston Scientific, CryoLife, Edwards Lifesciences, LivaNova, & Medtronic
- Neuromodulation Market 2023 report provides Latest improvements in the industry by anticipating the future perspective of the market, competitors, the top key players such as Medtronic plc, St. Jude Medical, Inc., LivaNova PLC
- Cardiopulmonary Bypass Equipment Market Expected to Witness the Highest Growth 2026 | With Global Key Players Medtronic Plc, LivaNova PLC, MAQUET Holding B.V. & Co. KG., Terumo Corporation, Braile Biomedica, Tianjin Medical
- Global Cardiac Prosthetic Devices Market Attractiveness, Competitive Landscape and Key Players Boston scientific, Medtronic, Livanova, Edward lifesciences, ST.jude medical, Elkem Silicones, Integer Holdings Corporation, Getinge AB
Livanova Office Locations
Livanova has an office in London
London, GB (HQ)
20 Eastbourne Terrace
Livanova Financials and Metrics
Livanova Revenue
Livanova's revenue was reported to be $1.11 b in FY, 2018
| USD | |
|---|---|
Revenue (Q1, 2019) | 250.8m |
Net income (Q1, 2019) | (14.8m) |
Market capitalization (16-May-2019) | 3.5b |
Closing stock price (16-May-2019) | 73.1 |
Cash (31-Mar-2019) | 50.8m |
Livanova's current market capitalization is $3.5 b.
Annual
Quarterly
| USD | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 287.0m | 321.0m | 295.3m | 285.1m | 321.4m | 309.7m | 250.4m | 287.5m | 272.1m | 250.8m |
Cost of goods sold | 123.6m | 130.7m | 106.5m | 101.5m | 108.9m | 108.2m | 84.6m | 92.0m | 94.3m | |
Gross profit | 163.4m | 190.4m | 188.8m | 183.6m | 212.5m | 201.4m | 165.8m | 195.5m | 177.8m | |
Gross profit Margin, % | 57% | 59% | 64% | 64% | 66% | 65% | 66% | 68% | 65% |
Annual
Quarterly
| USD | Q1, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 |
|---|---|---|---|---|---|---|---|---|---|
Cash | 87.5m | 63.6m | 62.7m | 42.7m | 65.2m | 65.0m | 47.4m | 79.9m | 50.8m |
Accounts Receivable | 288.5m | 284.3m | 271.5m | 305.4m | 314.0m | 279.8m | |||
Inventories | 210.8m | 197.6m | 192.4m | 204.7m | 214.6m | 154.3m | 157.8m | 153.1m | 161.3m |
Current Assets | 683.7m | 647.3m | 660.7m | 671.4m | 722.1m | 848.1m | 554.7m | 573.2m | 540.6m |
Annual
Quarterly
| USD | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|
Net Income | (40.4m) | (31.4m) | (33.0m) | 11.3m | 58.8m | 86.6m | 13.3m | 28.3m | 21.2m | (14.8m) |
Depreciation and Amortization | 23.6m | 41.7m | 64.2m | 20.2m | 41.1m | 63.3m | 17.1m | 35.2m | 53.0m | 16.9m |
Inventories | 10.8m | 24.7m | 20.6m | (4.4m) | (6.9m) | (11.0m) | (6.3m) | (11.3m) | (7.6m) | (8.3m) |
Cash From Operating Activities | 9.6m | 12.6m | 49.3m | 33.2m | 31.6m | 73.7m | 20.4m | 48.5m | 99.6m | 2.0m |
| USD | Y, 2019 |
|---|---|
Financial Leverage | 1.7 x |
Livanova Online and Social Media Presence
Livanova News and Updates
May 02, 2019
Global Heart Valve Repair and Replacement Devices Market to 2023 - Key Vendors are Abbott, Boston Scientific, CryoLife, Edwards Lifesciences, LivaNova, & Medtronic
DUBLIN, May 2, 2019 /PRNewswire/ -- The "Global Heart Valve Repair and Replacement Devices Market 2019-2023" report has been added to ResearchAndMarkets.com's offering. The analysts have predicted that the heart valve repair and replacement devices market will register a CAGR of nearly...
January 16, 2019
Neuromodulation Market 2023 report provides Latest improvements in the industry by anticipating the future perspective of the market, competitors, the top key players such as Medtronic plc, St. Jude Medical, Inc., LivaNova PLC
The Global Neuromodulation Market is an analysis and portrayal of the market globally. It gives a clear image of the market and a thoughtful knowledge about its segments. The various sections are examined and is the key part of the Neuromodulation Market. Posted via Industry Today. Follow us on Twit…
January 15, 2019
Cardiopulmonary Bypass Equipment Market Expected to Witness the Highest Growth 2026 | With Global Key Players Medtronic Plc, LivaNova PLC, MAQUET Holding B.V. & Co. KG., Terumo Corporation, Braile Biomedica, Tianjin Medical
Cardiopulmonary bypass equipment is a machine which takes over the function of heart and lungs to maintain the circulation of blood and the oxygen content of the patient's body during coronary bypass heart surgery. Posted via Industry Today. Follow us on Twitter @IndustryToday
December 07, 2018
Global Cardiac Prosthetic Devices Market Attractiveness, Competitive Landscape and Key Players Boston scientific, Medtronic, Livanova, Edward lifesciences, ST.jude medical, Elkem Silicones, Integer Holdings Corporation, Getinge AB
Market research Report on Cardiac Prosthetic Devices industry providing global and Chinese Market Landscape and its Growth Prospects over the approaching years until 2025 is currently offered at The Insight Partners Posted via Industry Today. Follow us on Twitter @IndustryToday
November 27, 2018
Global Annuloplasty Rings Market Is Expected To Reach Usd 492.65 Million By 2022 Along With The Keyplayers As Medtronic, Edwards Lifesciences Corporation, Abbott, Livanova Plc, Braile Biomédica, Labcor Laboratórios Ltda
Qurate Business Intelligence added “Breast Implants Market” to its research database with information such as company profiles, product picture and specification. Posted via Industry Today. Follow us on Twitter @IndustryToday
October 30, 2018
Global Cannula Market Analysis & Forecast Report 2018-2025 Featuring Innovators - Smith and Nephew, Smiths Medical, Teleflex & Livanova
DUBLIN, Oct. 30, 2018 /PRNewswire/ -- The "Cannula Market Size, Share & Trends Analysis Report By Product (Dermatology, Cardiac, Nasal), By Type, By Material, By Size, By End Use (Hospital, ASC), And Segment Forecasts, 2018 - 2026" report has been added to ResearchAndMarkets.com's...
Livanova Frequently Asked Questions
When was Livanova founded?
Livanova was founded in 2015.
How many employees does Livanova have?
Livanova has 4,000 employees.
What is Livanova revenue?
Latest Livanova annual revenue is $1.1 b.
What is Livanova revenue per employee?
Latest Livanova revenue per employee is $276.7 k.
Who are Livanova competitors?
Competitors of Livanova include C. R. Bard, Integra LifeSciences and Teleflex.
Where is Livanova headquarters?
Livanova headquarters is located at 20 Eastbourne Terrace, London.
Where are Livanova offices?
Livanova has an office in London.
How many offices does Livanova have?
Livanova has 1 office.